HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan

Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer

NCT00364715 ·Status: COMPLETED

Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

NCT04626440 ·Status: RECRUITING

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

NCT00685750 ·Status: TERMINATED ·Phase: NA

The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

NCT00302562 ·Status: UNKNOWN

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

NCT00991991 ·Status: TERMINATED

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

NCT04060485 ·Status: UNKNOWN

Genomics and Prognosis in GI Cancers

NCT05767697 ·Status: RECRUITING

Different Genetic Features Associated With Hepatic Carcinogenesis

NCT01247506 ·Status: UNKNOWN

Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study

NCT06883565 ·Status: COMPLETED

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

NCT01567722 ·Status: TERMINATED

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

NCT00581750 ·Status: COMPLETED

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia

NCT05687149 ·Status: RECRUITING

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

NCT03108885 ·Status: TERMINATED

Whole-Exome Sequencing (WES) of Cancer Patients

NCT02127359 ·Status: COMPLETED

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

NCT00450593 ·Status: UNKNOWN

5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients

NCT06667583 ·Status: NOT_YET_RECRUITING

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

NCT04509804 ·Status: COMPLETED

Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

NCT04821895 ·Status: ACTIVE_NOT_RECRUITING

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

NCT02178163 ·Status: RECRUITING ·Phase: NA

The Role of POLE Mutation in High Risk Endometrial Cancer.

NCT07114653 ·Status: RECRUITING

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

NCT01062438 ·Status: COMPLETED

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

NCT00155896 ·Status: UNKNOWN

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

NCT01345513 ·Status: COMPLETED

Family Study of Head and Neck Cancers in Taiwan

NCT00342147 ·Status: COMPLETED

The Development of Human Immunologic Assays Specific to Folate Receptor Antigen

NCT00155935 ·Status: UNKNOWN ·Phase: NA